Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:19 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006368
Protocol Section: NCT00006368
Start Identification Module Data
Brief Title: Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Official Title: A Phase I Open-Label Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors
Acronym: None
Organization: Novartis
Organization Class: INDUSTRY
Organization Study ID: NOVARTIS-SMT-B151
Secondary IDs
Secondary ID Type Domain Link
NCI-G00-1857 Registry Identifier PDQ Physician Data Query None
MCC-12275 None None None
MCC-IRB-5473 None None None
CDR0000068241 REGISTRY None None
Start Status Module Data
Status Verified Date: 2013-04
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Novartis Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Novartis Pharmaceuticals
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload